Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Pablo Tebas, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01300988
First received: December 16, 2010
Last updated: January 7, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)